ES2167611T3 - Formulaciones de gel que contienen factores de crecimiento. - Google Patents
Formulaciones de gel que contienen factores de crecimiento.Info
- Publication number
- ES2167611T3 ES2167611T3 ES96935936T ES96935936T ES2167611T3 ES 2167611 T3 ES2167611 T3 ES 2167611T3 ES 96935936 T ES96935936 T ES 96935936T ES 96935936 T ES96935936 T ES 96935936T ES 2167611 T3 ES2167611 T3 ES 2167611T3
- Authority
- ES
- Spain
- Prior art keywords
- gel
- growth factors
- gel preparations
- formulations containing
- gel formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003102 growth factor Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 4
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000002491 angiogenic effect Effects 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 230000002297 mitogenic effect Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
SE PRESENTAN PREPARADOS DE GEL QUE CONTIENEN FACTORES DE CRECIMIENTO POLIPEPTIDICOS CON ACTIVIDAD MITOGENICA O ANGIOGENICA HUMANAS. LOS PREPARADOS DE GEL SON UTILES PARA EL TRATAMIENTO TOPICO O DE INCISIONES EN HERIDAS CUTANEAS, ESPECIALMENTE DE LA CAMARA ANTERIOR DEL OJO. LOS PREPARADOS DE GEL INCLUYEN TAMBIEN UN POLIMERO HIDROSOLUBLE, FARMACEUTICA U OFTALMICAMENTE COMPATIBLE, QUE APORTA LA VISCOSIDAD DENTRO DE DIFERENTES MARGENES DETERMINADOS POR LA APLICACION DEL GEL. LOS PREPARADOS DE GEL PERMITEN UNA LIBERACION CONTROLADA Y UN MAYOR TIEMPO DE CONTACTO DEL FACTOR DE CRECIMIENTO CON LA HERIDA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/539,898 US5705485A (en) | 1987-09-18 | 1995-10-06 | Gel formulations containing growth factors |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2167611T3 true ES2167611T3 (es) | 2002-05-16 |
Family
ID=24153118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96935936T Expired - Lifetime ES2167611T3 (es) | 1995-10-06 | 1996-09-24 | Formulaciones de gel que contienen factores de crecimiento. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5705485A (es) |
EP (1) | EP0859596B1 (es) |
JP (1) | JP4001382B2 (es) |
KR (1) | KR100444417B1 (es) |
CN (1) | CN1142791C (es) |
AT (1) | ATE209900T1 (es) |
AU (1) | AU706806B2 (es) |
BR (1) | BR9610790A (es) |
CA (1) | CA2234235C (es) |
CZ (1) | CZ294676B6 (es) |
DE (1) | DE69617723T2 (es) |
DK (1) | DK0859596T3 (es) |
ES (1) | ES2167611T3 (es) |
HU (1) | HU223880B1 (es) |
NO (1) | NO981539L (es) |
PL (1) | PL187174B1 (es) |
PT (1) | PT859596E (es) |
WO (1) | WO1997012601A2 (es) |
ZA (1) | ZA968398B (es) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6636098A (en) * | 1998-03-07 | 1999-09-20 | Dae Woong Pharmaceutical Co., Ltd. | Topical composition containing human epidermal growth factor |
US20030147860A1 (en) * | 2002-02-07 | 2003-08-07 | Marchosky J. Alexander | Compositions and methods for forming and strengthening bone |
ATE363292T1 (de) * | 1998-09-04 | 2007-06-15 | Scios Inc | Hydrogelzusammensetzungen mit kontrollierter freigabe von wachstumsfaktoren |
US6057280A (en) | 1998-11-19 | 2000-05-02 | Huish Detergents, Inc. | Compositions containing α-sulfofatty acid esters and methods of making and using the same |
DE19925519A1 (de) | 1999-06-04 | 2000-12-07 | Lohmann Therapie Syst Lts | Wundauflage zur gesteuerten Abgabe von Wirkstoff an Wunden und Verfahren zu ihrer Herstellung |
AU5624500A (en) * | 1999-06-18 | 2001-01-09 | Collaborative Group, Ltd., The | Hyaluronic acid microspheres for sustained gene transfer |
US8188043B2 (en) * | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
CA2390556C (en) | 1999-11-09 | 2009-05-19 | Denki Kagaku Kogyo Kabushiki Kaisha | Use of soluble cellulose derivative having been made hardly soluble in water and method for producing it |
DE10048260A1 (de) * | 2000-09-29 | 2002-04-11 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Aminoguanidin und/oder dessen Derivaten und Strukturanaloga zur Hautaufhellung von Altersflecken und/oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung |
US6703039B2 (en) * | 2000-12-06 | 2004-03-09 | Bausch & Lomb Incorporated | Reversible gelling system for ocular drug delivery |
EP1355659A2 (en) * | 2001-01-26 | 2003-10-29 | Genetix Pharmaceuticals Inc. | Use of compositions containing pdgf-bb for promoting angiogenesis |
DE10140623A1 (de) * | 2001-08-18 | 2003-03-06 | Nawa Heilmittel Gmbh | Pharmazeutisches Präparat zur Behandlung von Wunden |
US6835536B2 (en) | 2001-08-21 | 2004-12-28 | Micrologix Biotech Inc. | Antimicrobial cationic peptides and formulations thereof |
US7037504B2 (en) * | 2001-10-23 | 2006-05-02 | Waratah Pharmaceuticals, Inc. | Epidermal growth factor protein and gene, and methods of use therefor |
US20080086792A1 (en) | 2006-10-13 | 2008-04-17 | Thomas Charles Kuracina | Method and apparatus for diverting sweat, liquid, moisture or the like from an eye |
CA2476653C (en) | 2002-02-21 | 2009-01-27 | Encelle, Inc. | Cross-linked bioactive hydrogel matrices |
US20030220632A1 (en) * | 2002-05-23 | 2003-11-27 | Wolfgang Strasser | Method of using gel sheets for laser treatment |
DE60335997D1 (de) * | 2002-09-16 | 2011-03-24 | Agennix Inc | Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus |
WO2005014046A2 (en) * | 2003-08-07 | 2005-02-17 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes and methods for making and using the same |
US8062661B2 (en) | 2003-12-11 | 2011-11-22 | Teikoku Pharma Usa, Inc. | Methods and compositions for treating skin wounds |
CN100411615C (zh) * | 2003-12-12 | 2008-08-20 | 上海第二医科大学附属瑞金医院 | 氨基胍对难愈创面的防治作用 |
WO2005077402A1 (en) * | 2004-02-11 | 2005-08-25 | Virchow Biotech Private Limited | Honey based gel formulations |
US20060036271A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification devices |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9801913B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Barrier layer |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
KR20080017362A (ko) * | 2005-06-17 | 2008-02-26 | 제넨테크, 인크. | 창상 치유를 위한 vegf의 용도 |
WO2007013100A1 (en) * | 2005-07-26 | 2007-02-01 | Virchow Biotech Private Limited | Gel formulation comprising platelet derived growth factor |
US8696671B2 (en) * | 2005-07-29 | 2014-04-15 | Vertos Medical Inc. | Percutaneous tissue excision devices |
US20070055263A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Tools for Percutaneous Spinal Ligament Decompression and Device for Supporting Same |
FR2891149B1 (fr) * | 2005-09-26 | 2007-11-30 | Biodex Sarl | Composition pharmaceutique a action cicatrisante comprenant un derive de dextrane soluble et un facteur de croissance derive des plaquettes. |
US9278161B2 (en) * | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
DE102005055275A1 (de) * | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
KR100687281B1 (ko) * | 2005-11-30 | 2007-02-27 | 한국과학기술연구원 | 생리 활성 물질이 결합된 조직 재생용 주입형 온도 감응성플루로닉 유도체 하이드로겔 및 이의 제조 방법 |
KR100742313B1 (ko) * | 2006-03-21 | 2007-07-24 | 퓨리메드 주식회사 | 신규한 혈소판 유래 성장 인자(pdgf) b 폴리펩타이드및 이의 유전자 |
US7942830B2 (en) | 2006-05-09 | 2011-05-17 | Vertos Medical, Inc. | Ipsilateral approach to minimally invasive ligament decompression procedure |
KR100784134B1 (ko) * | 2006-10-09 | 2007-12-12 | 주식회사 대웅 | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 |
KR101437191B1 (ko) * | 2006-10-26 | 2014-09-03 | 센주 세이야꾸 가부시키가이샤 | 안과용 수성 액제 |
US8343536B2 (en) | 2007-01-25 | 2013-01-01 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
US20080221383A1 (en) * | 2007-02-12 | 2008-09-11 | Vertos Medical, Inc. | Tissue excision devices and methods |
US20090118709A1 (en) * | 2007-11-06 | 2009-05-07 | Vertos Medical, Inc. A Delaware Corporation | Tissue Excision Tool, Kits and Methods of Using the Same |
JP5582711B2 (ja) * | 2008-09-25 | 2014-09-03 | 株式会社エー・アイ・システムプロダクト | ローション状の塗薬 |
USD611146S1 (en) | 2008-10-23 | 2010-03-02 | Vertos Medical, Inc. | Tissue modification device |
USD619253S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
USD621939S1 (en) | 2008-10-23 | 2010-08-17 | Vertos Medical, Inc. | Tissue modification device |
USD619252S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
USD610259S1 (en) | 2008-10-23 | 2010-02-16 | Vertos Medical, Inc. | Tissue modification device |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
PT2480204E (pt) * | 2009-09-22 | 2014-01-22 | Vlife Sciences Technologies Pvt Ltd | Formulação tópica para úlceras do pé diabético |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
WO2013005235A1 (en) * | 2011-07-06 | 2013-01-10 | Orf Liftaekni Hf | Method of use of stabilised non-plant-derived growth factor in skin care |
WO2013067195A1 (en) | 2011-11-02 | 2013-05-10 | Halscion, Inc. | Methods and compositions for wound treatment |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
US9422497B2 (en) | 2012-09-21 | 2016-08-23 | Exxonmobil Research And Engineering Company | Synthetic lubricant basestocks and methods of preparation thereof |
SG11201507429TA (en) | 2013-03-15 | 2015-10-29 | Genentech Inc | Il-22 polypeptides and il-22 fc fusion proteins and methods of use |
EP2968462B1 (en) | 2013-03-15 | 2020-12-23 | The Jackson Laboratory | Methods for promoting wound healing and hair growth |
US9675537B2 (en) | 2014-06-30 | 2017-06-13 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
EP3206670A4 (en) | 2014-10-14 | 2018-06-20 | Samuel Lynch | Compositions for treating wounds |
WO2017035280A1 (en) * | 2015-08-24 | 2017-03-02 | Nugene, Inc. | Skin damage healing aids and dressings |
EP3419669A4 (en) * | 2016-02-23 | 2019-10-30 | Matripharm International Inc. | DOUBLE-SPEED RELEASE COMPOSITION WITH HIGH MEDICAL DRUG CHARGE |
AU2018269057B2 (en) * | 2017-05-18 | 2024-07-18 | The Board Of Trustees Of The Leland Stanford Junior University | Targeted in situ therapeutic delivery of secreted factors from stem cells for treatment of damaged tissue |
DK3743088T3 (da) | 2018-01-26 | 2022-12-19 | Hoffmann La Roche | IL-22 Fc-sammensætninger og fremgangsmåder til anvendelse |
EP3743437A1 (en) | 2018-01-26 | 2020-12-02 | F. Hoffmann-La Roche AG | Il-22 fc fusion proteins and methods of use |
CA3091139A1 (en) | 2018-02-21 | 2019-08-29 | Genentech, Inc. | Dosing for treatment with il-22 fc fusion proteins |
CN114601959A (zh) * | 2020-11-23 | 2022-06-10 | 山东融元康医疗科技有限公司 | 一种医用皮肤护理敷料及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1190361B (it) * | 1985-05-30 | 1988-02-16 | Zambon Spa | Composizione farmaceutica in crema per uso dermale ed oftalmico |
NZ235556A (en) * | 1986-11-05 | 1991-06-25 | Ethicon Inc | Breast milk substitute containing recombinant human egf |
US4717717A (en) * | 1986-11-05 | 1988-01-05 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
US5124316A (en) * | 1986-11-14 | 1992-06-23 | President And Fellows Of Harvard College | Method for periodontal regeneration |
US5457093A (en) * | 1987-09-18 | 1995-10-10 | Ethicon, Inc. | Gel formulations containing growth factors |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
AU663328B2 (en) * | 1991-06-21 | 1995-10-05 | Genetics Institute, Llc | Pharmaceutical formulations of osteogenic proteins |
HUT67319A (en) * | 1991-08-30 | 1995-03-28 | Life Medical Sciences Inc | Compositions for treating wounds |
AU3062392A (en) * | 1991-11-04 | 1993-06-07 | Novo Nordisk A/S | Pdgf gel formulation |
JP3102655B2 (ja) * | 1991-12-27 | 2000-10-23 | 住友製薬株式会社 | 超音波制御による薬物放出製剤 |
-
1995
- 1995-10-06 US US08/539,898 patent/US5705485A/en not_active Expired - Lifetime
-
1996
- 1996-09-24 BR BR9610790A patent/BR9610790A/pt not_active IP Right Cessation
- 1996-09-24 CZ CZ19981024A patent/CZ294676B6/cs not_active IP Right Cessation
- 1996-09-24 DE DE69617723T patent/DE69617723T2/de not_active Expired - Lifetime
- 1996-09-24 EP EP96935936A patent/EP0859596B1/en not_active Expired - Lifetime
- 1996-09-24 AT AT96935936T patent/ATE209900T1/de not_active IP Right Cessation
- 1996-09-24 JP JP51430597A patent/JP4001382B2/ja not_active Expired - Fee Related
- 1996-09-24 AU AU73707/96A patent/AU706806B2/en not_active Ceased
- 1996-09-24 CA CA002234235A patent/CA2234235C/en not_active Expired - Fee Related
- 1996-09-24 ES ES96935936T patent/ES2167611T3/es not_active Expired - Lifetime
- 1996-09-24 CN CNB961987731A patent/CN1142791C/zh not_active Expired - Fee Related
- 1996-09-24 HU HU9803002A patent/HU223880B1/hu not_active IP Right Cessation
- 1996-09-24 PL PL96326064A patent/PL187174B1/pl not_active IP Right Cessation
- 1996-09-24 KR KR10-1998-0702519A patent/KR100444417B1/ko not_active IP Right Cessation
- 1996-09-24 DK DK96935936T patent/DK0859596T3/da active
- 1996-09-24 WO PCT/US1996/015288 patent/WO1997012601A2/en active IP Right Grant
- 1996-09-24 PT PT96935936T patent/PT859596E/pt unknown
- 1996-10-04 ZA ZA9608398A patent/ZA968398B/xx unknown
-
1998
- 1998-04-03 NO NO981539A patent/NO981539L/no unknown
Also Published As
Publication number | Publication date |
---|---|
BR9610790A (pt) | 1999-07-13 |
PT859596E (pt) | 2002-05-31 |
PL326064A1 (en) | 1998-08-17 |
KR19990064041A (ko) | 1999-07-26 |
HUP9803002A2 (hu) | 1999-04-28 |
CA2234235A1 (en) | 1997-04-10 |
NO981539L (no) | 1998-06-02 |
HU223880B1 (hu) | 2005-02-28 |
EP0859596A2 (en) | 1998-08-26 |
NO981539D0 (no) | 1998-04-03 |
HUP9803002A3 (en) | 2001-08-28 |
US5705485A (en) | 1998-01-06 |
AU706806B2 (en) | 1999-06-24 |
JPH11512740A (ja) | 1999-11-02 |
ZA968398B (en) | 1998-04-06 |
DE69617723T2 (de) | 2002-05-08 |
EP0859596B1 (en) | 2001-12-05 |
AU7370796A (en) | 1997-04-28 |
PL187174B1 (pl) | 2004-05-31 |
CN1211191A (zh) | 1999-03-17 |
DE69617723D1 (de) | 2002-01-17 |
DK0859596T3 (da) | 2002-03-04 |
CN1142791C (zh) | 2004-03-24 |
JP4001382B2 (ja) | 2007-10-31 |
CZ102498A3 (cs) | 1999-08-11 |
ATE209900T1 (de) | 2001-12-15 |
WO1997012601A3 (en) | 1997-05-01 |
CA2234235C (en) | 2002-05-14 |
CZ294676B6 (cs) | 2005-02-16 |
KR100444417B1 (ko) | 2004-11-03 |
WO1997012601A2 (en) | 1997-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2167611T3 (es) | Formulaciones de gel que contienen factores de crecimiento. | |
IL115721A (en) | Device for the modulation of cell proliferation and wound healing and methods for its preparation | |
WO1995028124A3 (en) | An adjunctive polymer system for use with medical device | |
GR3034921T3 (en) | Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer. | |
ES2072563T3 (es) | Composicion para el tratamiento cosmetico y/o farmaceutico de las capas superiores de la epidermis por aplicacion topica sobre la piel y procedimiento de preparacion correspondiente. | |
TW368411B (en) | Biocompatible ocular implants | |
CA2030459A1 (en) | Biodegradable ocular implants | |
EP2338448A3 (en) | Anti-inflammatory and antimicrobial uses for bioactive glass | |
AU1189792A (en) | Biodegradable and bioabsorbable guide channels for use in nerve treatment and regeneration | |
DK0790823T3 (da) | Lægemiddelafgivende kirurgisk implantat eller forbindingsmateriale | |
ES2136618T3 (es) | Cicatrizacion de heridas. | |
ES2095337T3 (es) | Preparacion de pranoprofen de liberacion sostenida. | |
WO1995016435A3 (en) | Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent | |
BG101802A (en) | Medicamentous form for the treatment of wounds with collagenese and method for its preparation | |
Sawada et al. | A silicone gel sheet dressing containing an antimicrobial agent for split thickness donor site wounds | |
FR2757064B1 (fr) | Lentille intraoculaire contenant un medicament relargable | |
ES2182840T3 (es) | Factor xiii para el tratamiento de heridas de la piel. | |
Szycher et al. | Spandra®: A Sustained Release Battlefield Wound Dressing | |
UA64800C2 (uk) | Очний антисептик | |
DE69614577D1 (de) | Polyamin-antagonisten enthaltende intraokulare irrigationslösung | |
AU643772B2 (en) | Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use | |
RU95107940A (ru) | Способ хирургического лечения макулодистрофий различного генеза | |
BG60887B1 (en) | Thienethiopyran sulphonamide derivatives and their application in ophthalmological preparations |